David Shook - 20 Jun 2023 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Chief Medical Officer
Signature
/s/ Alicia Hager, as Attorney-in-Fact
Issuer symbol
NKTX
Transactions as of
20 Jun 2023
Net transactions value
-$2,129
Form type
4
Filing time
22 Jun 2023, 16:22:55 UTC
Previous filing
18 Jan 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTX Common Stock Sale $2,129 -439 -0.7% $4.85 61,863 20 Jun 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
F2 Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2023.